Ye Dong, Shen Zhisen, Zhou Shuihong
Department of Otorhinolaryngology - Head and Neck Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China,
Department of Otorhinolaryngology -Head and Neck Surgery, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.
Cancer Manag Res. 2019 Jan 22;11:969-979. doi: 10.2147/CMAR.S191696. eCollection 2019.
miRNAs are single-stranded small RNAs that do not encode proteins. They can combine complementarily with the 3'-UTRs of target gene mRNA molecules to promote targeted mRNA degradation or inhibit mRNA translation, thereby regulating gene expression at the post-transcriptional level. MiRNAs participate in regulation of cell cycling, growth, apoptosis, differentiation, and stress responses. MiRNA-145 (miR-145) is a tumor suppressor that targets various tumor-specific genes and proteins, thereby influencing related signaling pathways. MiR-145 not only regulates tumor growth, invasion, and metastasis, but is also important for tumor angiogenesis and tumor stem cell proliferation. Here, we review the roles and mechanisms of miR-145 in the diagnosis and treatment of malignant tumors. Published data confirm that miR-145 expression in various tumors is significantly lower than that in normal tissues and that overexpression of miR-145 inhibits the growth of different tumor cells, significantly reduces the ability of tumors to spread, and improves sensitivity to chemotherapeutic drugs. We conclude that miR-145 is a potential marker for use in the early diagnosis and prognostic evaluation of patients with cancer, has a role as a tumor suppressor, and is a promising cancer treatment target candidate.
微小RNA(miRNAs)是一类不编码蛋白质的单链小RNA。它们能够与靶基因mRNA分子的3'-非翻译区(3'-UTR)互补结合,从而促进靶向mRNA的降解或抑制mRNA的翻译,进而在转录后水平调控基因表达。微小RNA参与细胞周期、生长、凋亡、分化及应激反应的调控。微小RNA-145(miR-145)是一种肿瘤抑制因子,可作用于多种肿瘤特异性基因和蛋白质,进而影响相关信号通路。miR-145不仅能调控肿瘤的生长、侵袭和转移,对肿瘤血管生成及肿瘤干细胞增殖也具有重要作用。在此,我们综述miR-145在恶性肿瘤诊断和治疗中的作用及机制。已发表的数据证实,miR-145在多种肿瘤中的表达显著低于正常组织,miR-145的过表达可抑制不同肿瘤细胞的生长,显著降低肿瘤的转移能力,并提高对化疗药物的敏感性。我们得出结论,miR-145是一种可用于癌症患者早期诊断和预后评估的潜在标志物,具有肿瘤抑制作用,是一个有前景的癌症治疗靶点候选物。